Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASO Visual Abstract: Tumor Burden Modifies the Prognostic Impact of Adequate Lymph Node Dissection in Patients Undergoing Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.

Annals of surgical oncology·2026
Same author

Outcomes of Liver Transplant Versus Partial Hepatectomy for Perihilar Cholangiocarcinoma Patients Requiring Arterial Reconstruction.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Surgical Outcomes from Nationwide Implementation of the International Best-Practice for Locally Advanced Pancreatic Cancer (PREOPANC-4) study.

The British journal of surgery·2026
Same author

Hepatic artery infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: Pooled individual patient-level analysis of four clinical trials.

Journal of hepatology·2026
Same author

Metastatic Lymph Node Burden and Invasive Tumour Features Inform First Recurrence Patterns After Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.

The British journal of surgery·2026
Same author

Preoperative ALBI and APRI are independently associated with liver-related complications after curative-intent hepatectomy.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026
Same journal

Public Health Response to Clade Ib Mpox with Multiple Exposures in Congregate Living Settings - New Hampshire, February 2025.

NEJM evidence·2026
Same journal

Berberine-Ursodeoxycholate - Bringing Traditional Chinese Medicine to Our World.

NEJM evidence·2026
Same journal

Outbreak of Legionnaires' Disease Associated with Cooling Tower Systems in Central Harlem.

NEJM evidence·2026
Same journal

Immunotherapy for Fertility in Autoimmune Premature Ovarian Insufficiency.

NEJM evidence·2026
Same journal

A Randomized Trial of Interval Likelihood Ratios for Clinical Decision-Making.

NEJM evidence·2026
Same journal

Evidence for Evidence-Based Medicine - A Call for Some Theory and a New Problem.

NEJM evidence·2026
See all related articles

Related Experiment Video

Updated: Jan 10, 2026

Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video
10:04

Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video

Published on: June 6, 2020

10.1K

Minimally Invasive versus Open Pancreatoduodenectomy for Resectable Neoplasms.

Nine de Graaf1,2,3, Anouk M L H Emmen1,2,3, Marco Ramera3,4

  • 1Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

NEJM Evidence
|November 25, 2025
PubMed
Summary
This summary is machine-generated.

Minimally invasive pancreatoduodenectomy (MIPD) is noninferior to open pancreatoduodenectomy (OPD) for overall complications in patients with resectable pancreatic cancer. MIPD also demonstrated a faster time to functional recovery, suggesting improved patient outcomes.

More Related Videos

Laparoscopic Pancreatoduodenectomy With Modified Blumgart Pancreaticojejunostomy
08:57

Laparoscopic Pancreatoduodenectomy With Modified Blumgart Pancreaticojejunostomy

Published on: June 17, 2018

15.8K
Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
12:34

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Published on: January 3, 2020

17.2K

Related Experiment Videos

Last Updated: Jan 10, 2026

Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video
10:04

Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video

Published on: June 6, 2020

10.1K
Laparoscopic Pancreatoduodenectomy With Modified Blumgart Pancreaticojejunostomy
08:57

Laparoscopic Pancreatoduodenectomy With Modified Blumgart Pancreaticojejunostomy

Published on: June 17, 2018

15.8K
Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
12:34

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Published on: January 3, 2020

17.2K

Area of Science:

  • Surgical Oncology
  • Gastroenterology
  • Minimally Invasive Surgery

Background:

  • Minimally invasive pancreatoduodenectomy (MIPD) may offer faster recovery than open pancreatoduodenectomy (OPD) for resectable pancreatic neoplasms.
  • The safety and efficacy of MIPD compared to OPD remain under investigation.

Purpose of the Study:

  • To determine if MIPD is noninferior to OPD regarding overall complications.
  • To assess if MIPD is superior to OPD in terms of time to functional recovery (TTFR).

Main Methods:

  • An international, multicenter, patient-blinded randomized noninferiority trial compared robot-assisted/laparoscopic MIPD with OPD.
  • 288 patients with resectable pancreatic or periampullary neoplasms were randomized (2:1 ratio).
  • Primary endpoint: overall complications within 90 days (Comprehensive Complication Index); Secondary endpoint: TTFR.

Main Results:

  • MIPD was noninferior to OPD (mean CCI: 33.4 vs 35.3, P=0.002).
  • Median TTFR was shorter for MIPD (7 days) versus OPD (8 days).
  • MIPD showed lower rates of pancreatic fistula and surgical site infection, but a higher 90-day mortality rate (4.7% vs 2.0%).

Conclusions:

  • Minimally invasive pancreatoduodenectomy is noninferior to open pancreatoduodenectomy for 90-day overall complications in patients with resectable pancreatic and periampullary neoplasms.